Novavax's shots were 90% effective at preventing illness overall and 100% effective at preventing severe disease when the alpha variant of Covid was dominant, according to clinical trial data. Oliver Brooks, a CDC vaccine committee member and chief medical officer at Watts HealthCare Corporation in Los Angeles. "The primary target population for Novavax will be the 10% to 13% of those that are unvaccinated," said Dr. Anywhere from 26 million to 37 million adults are still unvaccinated in the U.S., according to CDC data, but it's unclear how many of those people will opt to take Novavax's vaccine. Walensky, in a statement, said the Novavax vaccine will provide another option for people who do not want to take Pfizer's and Moderna's shots. adults, 77%, are now fully vaccinated with Pfizer, Moderna and to a much lesser degree Johnson & Johnson's shots, according to CDC data. at a time when more than three-fourths of U.S. The small Maryland biotech company received $1.8 billion of taxpayer money from Operation Warp Speed, but struggled to get its manufacturing base in place and ultimately fell behind Pfizer and Moderna. race to produce a vaccine to protect against Covid-19. The CDC's approval completes a two-year journey for Novavax, one of the early participants in the U.S. The Biden administration has secured 3.2 million doses of Novavax's vaccine so far, according to the Health and Human Services Department. The CDC, in a statement, said the vaccine will be available to the public in the coming weeks. Personal Loans for 670 Credit Score or Lower Personal Loans for 580 Credit Score or Lower Best Debt Consolidation Loans for Bad Credit
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |